MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

189.34
-0.40
-0.21%
Closed 16:00 08/06 EDT
OPEN
190.38
PREV CLOSE
189.74
HIGH
190.69
LOW
187.78
VOLUME
128.64K
TURNOVER
--
52 WEEK HIGH
199.83
52 WEEK LOW
104.28
MARKET CAP
9.96B
P/E (TTM)
30.70
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ICLR stock price target is 199.20 with a high estimate of 220.00 and a low estimate of 170.00.

EPS

ICLR News

More
ICON Plc -- Moody's affirms Baa3 issuer rating of ICON Plc, stable outlook
Moody's Investors Service, ("Moody's") has today affirmed the Baa3 long term issuer rating of ICON Plc ("ICON" or "the company"). ICON is strongly positioned in the Baa3 rating. Additionally, Moody's expects that ICON will continue to have strong Moody's-adj
Moody's · 07/30 17:30
Icon PLC: A CRO Momentum Stock Worth Backing Long Term
Seeking Alpha · 07/29 15:45
ICON Public Limited Company (ICLR): Were Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 07/28 00:29
UBS Maintains Neutral on Icon, Raises Price Target to $194
UBS maintains Icon (NASDAQ:ICLR) with a Neutral and raises the price target from $188 to $194.
Benzinga · 07/27 14:48
Deutsche Bank Maintains Hold on Icon, Raises Price Target to $170
Deutsche Bank maintains Icon (NASDAQ:ICLR) with a Hold and raises the price target from $135 to $170.
Benzinga · 07/27 12:22
ICON Public Limited Company 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 07/27 10:34
Icon PLC (ICLR) Q2 2020 Earnings Call Transcript
ICLR earnings call for the period ending June 30, 2020.
Motley Fool · 07/24 01:01
ICON's (ICLR) CEO Steven Cutler on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 07/23 19:38

Industry

Biotechnology & Medical Research
-0.96%
Pharmaceuticals & Medical Research
-0.46%

Hot Stocks

Symbol
Price
%Change

About ICLR

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
More

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.